nmm 22 4500ICPSR34083MiAaIm f a u cr mn mmmmuuuu150331s2012 miu f a eng d(MiAaI)ICPSR34083MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2010
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality
2015-01-20Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2012ICPSR34083NumericTitle from ICPSR DDI metadata of 2015-03-31.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR34083.v2
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrsuicideicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrNAHDAP I. National Addiction and HIV Data Archive ProgramICPSR IX. Health Care and Health FacilitiesSAMHDA VIII. Drug Abuse Warning Network (DAWN)United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and QualityInter-university Consortium for Political and Social Research.ICPSR (Series)34083Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR34083.v2 nmm 22 4500ICPSR31921MiAaIm f a u cr mn mmmmuuuu150331s2011 miu f a eng d(MiAaI)ICPSR31921MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2009
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality
2015-01-20Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2011ICPSR31921NumericTitle from ICPSR DDI metadata of 2015-03-31.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR31921.v3
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrsuicideicpsrSAMHDA VIII. Drug Abuse Warning Network (DAWN)ICPSR IX. Health Care and Health FacilitiesNAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and QualityInter-university Consortium for Political and Social Research.ICPSR (Series)31921Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR31921.v3 nmm 22 4500ICPSR31264MiAaIm f a u cr mn mmmmuuuu150331s2011 miu f a eng d(MiAaI)ICPSR31264MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2008
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality
2015-01-20Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2011ICPSR31264NumericTitle from ICPSR DDI metadata of 2015-03-31.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR31264.v5
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrsuicideicpsrSAMHDA VIII. Drug Abuse Warning Network (DAWN)NAHDAP I. National Addiction and HIV Data Archive ProgramICPSR IX. Health Care and Health FacilitiesUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and QualityInter-university Consortium for Political and Social Research.ICPSR (Series)31264Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR31264.v5 nmm 22 4500ICPSR33221MiAaIm f a u cr mn mmmmuuuu150331s2012 miu f a eng d(MiAaI)ICPSR33221MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2006
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2015-01-19Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2012ICPSR33221NumericTitle from ICPSR DDI metadata of 2015-03-31.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR33221.v2
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrsuicideicpsrICPSR IX. Health Care and Health FacilitiesNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA VIII. Drug Abuse Warning Network (DAWN)United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)33221Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR33221.v2 nmm 22 4500ICPSR33042MiAaIm f a u cr mn mmmmuuuu150331s2012 miu f a eng d(MiAaI)ICPSR33042MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2005
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies.
2015-01-19Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2012ICPSR33042NumericTitle from ICPSR DDI metadata of 2015-03-31.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR33042.v2
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrsuicideicpsrnonprescription drugsicpsrsubstance abuseicpsrICPSR IX. Health Care and Health FacilitiesSAMHDA VIII. Drug Abuse Warning Network (DAWN)NAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies.Inter-university Consortium for Political and Social Research.ICPSR (Series)33042Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR33042.v2 nmm 22 4500ICPSR33041MiAaIm f a u cr mn mmmmuuuu150331s2012 miu f a eng d(MiAaI)ICPSR33041MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2004
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2015-01-19Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2012ICPSR33041NumericTitle from ICPSR DDI metadata of 2015-03-31.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR33041.v2
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrsuicideicpsrICPSR IX. Health Care and Health FacilitiesNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA VIII. Drug Abuse Warning Network (DAWN)United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)33041Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR33041.v2 nmm 22 4500ICPSR32861MiAaIm f a u cr mn mmmmuuuu150331s2012 miu f a eng d(MiAaI)ICPSR32861MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2007
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2015-01-19Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2012ICPSR32861NumericTitle from ICPSR DDI metadata of 2015-03-31.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR32861.v3
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrsuicideicpsrICPSR IX. Health Care and Health FacilitiesNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA VIII. Drug Abuse Warning Network (DAWN)United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)32861Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR32861.v3